VFA
BLFS icon

Valeo Financial Advisors’s BioLife Solutions BLFS Stock Holding History

Valeo Financial Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-96
Closed -$3K – 675
2021
Q1 		$3K Sell
96
-91
-49% -$3.6K ﹤0.01% 1681
2020
Q4 		$7K Hold
187
– – ﹤0.01% 1273
2020
Q3 		$5K Buy
187
+72
+63% +$1.55K ﹤0.01% 1236
2020
Q2 		$2K Buy
+115
New +$1.58K ﹤0.01% 1728

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Valeo Financial Advisors's BLFS Position: Q2 2021 in Review

Valeo Financial Advisors sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 96 shares — an estimated $3K sold.

Valeo Financial Advisors first reported a position in BLFS in Q2 2020 and held it in 4 quarters. The position peaked at $7K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

  • Valeo Financial Advisors reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 96 BioLife Solutions shares in Q2 2021, an estimated $3K.
  • Valeo Financial Advisors first reported a position in BioLife Solutions in Q2 2020 and held it in 4 quarters.
  • Valeo Financial Advisors's BioLife Solutions position peaked at $7K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.